Prescription drug · BLA
Nufymco (Ranibizumab-leyk) NDC 70710-2173
Ranibizumab .5 mg/.05mL · Injection, Solution · Intravitreal · Zydus Pharmaceuticals USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70710-2173-1 | 70710217301 | 1 VIAL, GLASS in 1 CARTON (70710-2173-1) / .05 mL in 1 VIAL, GLASSMarketed from Jun 11, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Nufymco
- Generic name (nonproprietary)
- ranibizumab-leyk
- Active ingredients
- Ranibizumab — .5 mg/.05mL
- Dosage form
- Injection, Solution
- Route
- Intravitreal
- Labeler
- Zydus Pharmaceuticals USA Inc.NDC labeler code 70710
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761473
- Marketing start
- Listing expires
- Other FDA classes
- Vascular Endothelial Growth Factor Inhibitors (Mechanism)
- Identifiers
- Product ID 70710-2173_4a45dd5a-c8d9-4e98-9586-ab6c069c2ffeSPL ID 4a45dd5a-c8d9-4e98-9586-ab6c069c2ffeSPL set ID 05ed75bc-ae21-480b-9be4-cbc51689dd8aRxCUI 2744887, 2744894, 2744897, 2744900UNII ZL1R02VT79UPC 0370710217310
- Pharmacologic class
- Vascular Endothelial Growth Factor Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeMed-Code curated
J2778 — Injection, ranibizumab, 0.1 mg
Billing unit: 0.1 mg. Units on the claim = dose given ÷ 0.1 mg.
Ranibizumab biosimilars and the ranibizumab implant have their own HCPCS codes.
- Administration
Intravitreal injection procedure (CPT 67028)
The intravitreal injection is reported as a separate procedure from the drug supplied.
- NDC on a medical claim
N470710217301followed by a unit qualifier and the quantityPackage 70710-2173-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
NUFYMCO is indicated for the treatment of patients with: NUFYMCO, a vascular endothelial growth factor (VEGF) inhibitor, is indicated for the treatment of patients with: Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1.1 ) Macular Edema Following Retinal Vein Occlusion (RVO) ( 1.2 ) Diabetic Macular Edema (DME) ( 1.3 ) Diabetic Retinopathy (DR) ( 1.4 ) Myopic Choroidal Neovascularization (mCNV) ( 1.5 ) 1.1 Neovascular (Wet) Age-Related Macular Degeneration (AMD) 1.2 Macular Edema Following Retinal Vein Occlusion (RVO) 1.3 Diabetic Macular Edema (DME) 1.4 Diabetic Retinopathy (DR) 1.5 Myopic Choroidal Neovascularization (mCNV)
Excerpt only. Read the full label for complete information.
About NDC 70710-2173
- What is NDC 70710-2173?
- 70710-2173 is the product NDC for Nufymco (ranibizumab-leyk), Ranibizumab .5 mg/.05mL injection, solution, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Nufymco (Ranibizumab-leyk).
- What is the active ingredient?
- Ranibizumab.
- Who is the labeler?
- Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Nufymco?
- 1 other product NDC are listed under this name. See all Nufymco NDCs.
- Is there a related HCPCS / J-code?
- Yes: J2778, Injection, ranibizumab, 0.1 mg. See Billing references above.
Related NDCs: other Nufymco products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Nufymcoranibizumab-leyk | Ranibizumab .3 mg/.05mL | Injection, SolutionIntravitreal | Zydus Pharmaceuticals USA Inc. | 70710-2172 | 70710-2172-01 |
Other NDCs under BLA 761473
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Nufymcoranibizumab-leyk | Ranibizumab .3 mg/.05mL | Injection, SolutionIntravitreal | Zydus Pharmaceuticals USA Inc. | 70710-2172 |